Methylation Status of Genes Upregulated by Demethylating Agent 5-aza-2′-Deoxycytidine in Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|71|1-2|77-85

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.1-2, 2007-04, pp. : 77-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Effects of 5-Aza-2`-Deoxycytidine on DLC-1 Gene Expression, Methylation Level and Expression of Downstream Signaling Molecules Cdc42 in Multiple Myeloma

By  

Current Signal Transduction Therapy, Vol. 10, Iss. 1, 2015-01 ,pp. : 31-35

Bentham Science Publishers

Access to resources Recommend Favorite

The Synergistic Effect of 5-Aza-2′-Deoxycytidine and 5-Fluorouracil on Drug-Resistant Tumors

By  

Oncology, Vol. 71, Iss. 5-6, 2007-08 ,pp. : 437-445

Karger

Access to resources Recommend Favorite

Retinoic Acid Receptor-β Gene Reexpression and Biological Activity in SHI-1 Cells after Combined Treatment with 5-Aza-2′-Deoxycytidine and All-Trans Retinoic Acid

By  

Acta Haematologica, Vol. 133, Iss. 3, 2014-11 ,pp. : 279-286

Karger

Access to resources Recommend Favorite

DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1945-1956

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepcidin and DNA promoter methylation in hepatocellular carcinoma

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 48, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite